Bmc Medical Genomics

Bmc Medical Genomics

Bmc医学基因组学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Bmc Medical Genomics》是由BioMed Central出版社于2008年创办的英文国际期刊(ISSN: 1755-8794,E-ISSN: 1755-8794),该期刊长期致力于遗传学领域的创新研究,主要研究方向为医学-遗传学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表遗传学领域等方向的原创性研究为核心(研究类文章占比96.36%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在330篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Bmc Medical Genomics审稿周期约为 约3.5月 。该刊近年未被列入国际预警名单,年发文量约330篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 330 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
GENETICS & HEREDITY 遗传学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
GENETICS & HEREDITY 遗传学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GENETICS & HEREDITY SCIE Q3 117 / 191

39%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GENETICS & HEREDITY SCIE Q3 97 / 191

49.48%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.9 SJR:0.703 SNIP:0.581
学科类别 分区 排名 百分位
大类:Medicine 小类:Genetics (clinical) Q3 58 / 99

41%

大类:Medicine 小类:Genetics Q3 214 / 347

38%

期刊发文

  • Heterozygous variant in FGFR3 underlying severe phenotypes in the second trimester: a case report

    Author: Chen, Shujun; Dong, Hongmei; Luo, Yong; Zhang, Yingpin; Li, Pan

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01517-8

  • Causal effects of modifiable risk factors on kidney stones: a bidirectional mendelian randomization study

    Author: Liu, Wen; Wang, Miaomiao; Liu, Jianyong; Yan, Qiuxia; Liu, Ming

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01520-z

  • Genetic disorders and pregnancy outcomes of non-immune hydrops fetalis in a tertiary referral center

    Author: Guo, Danhua; He, Shuqiong; Lin, Na; Dai, Yifang; Li, Ying; Xu, Liangpu; Wu, Xiaoqing

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01505-y

  • Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma

    Author: Ding, Ruili; Zhao, Chuanbing; Jing, Yixin; Chen, Rong; Meng, Qingtao

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01504-z

  • De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia

    Author: Huang, Xiaoyu; Rui, Xue; Zhang, Shuang; Qi, Xiaolong; Rong, Weining; Sheng, Xunlun

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01516-9

  • Novel, heterozygous, de novo pathogenic variant (c.4963delA: p.Thr1656Glnfs*42) of the NF1 gene in a Chinese family with neurofibromatosis type 1

    Author: Yang, Lisha; Fu, Jiewen; Cheng, Jingliang; Zhou, Baixu; Chen, Maomei; Anuchapreeda, Songyot; Fu, Junjiang

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01514-x

  • A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma

    Author: Lin, Dezhao; Chen, Zhuoyan; Zeng, Yuan; Ding, Yinrong; Zhao, Luying; Xu, Qian; Yu, Fujun; Song, Xian; Zhu, Xiaohong

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01431-z

  • A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures

    Author: Zhuang, Jianlong; Xie, Meihua; Yao, Jianfeng; Fu, Wanyu; Zeng, Shuhong; Jiang, Yuying; Wang, Yuanbai; Xie, Yingjun; Wang, Gaoxiong; Chen, Chunnuan

    Journal: BMC MEDICAL GENOMICS. 2023; Vol. 16, Issue 1, pp. -. DOI: 10.1186/s12920-023-01433-x